Pharmaceutical-technological aspects of therapeutic systems for hormonal contraception [PDF]
Arhiv za farmaciju, 2016 The use of therapeutic systems for hormonal contraception (TSHC) represents an important alternative approach for prevention of unintended pregnancies in comparison to oral hormonal contraceptives, whereby the risk of gastrointestinal adverse effects ...
Đekić Ljiljana, Primorac Marija
doaj +1 more source
Treatment of symptoms of the menopause: an endocrine society clinical practice guideline [PDF]
, 2015 Objective: The objective of this document is to generate a practice guideline for the management and treatment of symptoms of the menopause. Participants: The Treatment of Symptoms of the Menopause Task Force included six experts, a methodologist, and
Davis, Susan R. +6 more
core +1 more source
Contraceptive Use in the United States [PDF]
, 2016 WHO NEEDS CONTRACEPTIVES?There are 61 million U.S. women in their childbearing years (15–44). About 43 million of them (70%) are at risk of unintended pregnancy—that is, they are sexually active and do not want to become pregnant, but could become ...
core
A randomised controlled trial evaluating the use of polyglactin (Vicryl) mesh, polydioxanone (PDS) or polyglactin (Vicryl) sutures for pelvic organ prolapse surgery : outcomes at 2 years [PDF]
, 2011 Peer ...
Allahdin, S +4 more
core +1 more source
Pharmacy, 2020 Annovera (segesterone acetate and ethinyl estradiol vaginal system) is a US Food and Drug Administration FDA-approved long-lasting, reversible contraceptive that is fully administered by the user and does not require a procedure for insertion or removal.
Jennifer J. Virro +5 more
doaj +1 more source
Contraceptive Vaginal Rings: Do They Pose an Increased Risk of Venous Thromboembolism in Aesthetic Surgery? [PDF]
, 2017 Nuvaring (Organon, Kenilworth, NJ) is a vaginal contraception ring inserted by the patient. It was approved by the Food and Drug Administration in 2001 for the prevention of pregnancy.
Matarasso, Alan +2 more
core
Effects of a novel estrogen-free, progesterone receptor modulator contraceptive vaginal ring on inhibition of ovulation, bleeding patterns and endometrium in normal women [PDF]
, 2012 BACKGROUND: Progesterone receptor modulators (PRMs) delivered by contraceptive vaginal rings provide an opportunity for development of an estrogen-free contraceptive that does not require daily oral intake of steroids.
Blithe, Diana +15 more
core +1 more source
AIDS (London), 2020 Objective: The antiretroviral-based dapivirine vaginal ring reduced HIV risk among women in phase III clinical trials. However, limited data exists on the impact of dapivirine on the vaginal microenvironment in adolescents.
C. Farr Zuend +10 more
semanticscholar +1 more source
Learning with the Amerindians: the evaluation of pelvic floor disorders among indigenous women who live in the Xingu Indian Park,Brazil [PDF]
, 2008 Objective: to evaluate the pelvic floor muscles and the incidence of pelvic organ prolapse among indigenous women who live in Xingu Indian Park, Mato Grosso, Brazil. Methods: observational study with 377 indigenous women, mean age 31+/-15 years,
Claudia Cristina Takano +3 more
core +2 more sources
PLoS ONE, 2019 The vaginal ring (VR) is a female-initiated drug-delivery platform used for different indications, including HIV pre-exposure prophylaxis (PrEP). We conducted a systematic review of VR acceptability, values and preferences among women in low- and middle ...
J. Griffin +7 more
semanticscholar +1 more source